EUVIMEDOpdag EUVIMED
Crossref

Azathioprine or Tofacitinib as Maintenance Therapy in Corticosteroid‐Responsive Acute Severe Ulcerative Colitis

Arshdeep Singh iD, Arshia Bhardwaj, Riya Sharma, Dharmatma Singh, Devanshi Jain, Namita Bansal, Gursimran Singh Kochhar, Vandana Midha, Ajit Sood

Alimentary Pharmacology & Therapeutics · 2025

DOI: 10.1111/apt.70246 ↗

At a glance

Journal article in Alimentary Pharmacology & Therapeutics, 2025. Written by Arshdeep Singh and 8 co-authors. Institution: Department of Gastroenterology, Dayanand Medical College and Hospital, Ludhiana, India. Major MEDLINE topics: Piperidines, Colitis, Ulcerative, Pyrimidines, Azathioprine. Cited 7 times so far (Crossref); 31 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

The optimal maintenance therapy for patients with acute severe ulcerative colitis (ASUC) remains unclear.

Aim

To evaluate the efficacy of azathioprine and tofacitinib in maintaining remission in patients with ASUC who respond to intravenous corticosteroids.

Methods

This propensity score–matched, retrospective cohort study evaluated the effectiveness and safety of azathioprine and tofacitinib as maintenance therapies in adult patients with ASUC responding to intravenous corticosteroids. We recorded rehospitalisation, corticosteroid reuse, therapeutic escalation, and colectomy. The primary endpoint was cumulative event‐free survival at 1 year. Adverse events were documented in both treatment arms.

Results

We included 115 patients in the final analysis (median age: 38 years [IQR: 28–49]; 54 females [46.95%]; 65 on azathioprine, 50 on tofacitinib). The cumulative probability of event‐free survival at 1 year was 44.0% with azathioprine and 75.0% with tofacitinib (log‐rank p = 0.01). Rates of rehospitalisation (15.4% v. 0%; p = 0.003) and therapeutic escalation (13.8% v. 2.0%; p = 0.02) were significantly greater in the azathioprine group. More patients receiving tofacitinib achieved symptomatic remission (40.0% v. 23.1%; p = 0.05), and combined symptomatic and biomarker remission (22.0% v. 16.9%; p = 0.49) at 1 year than those receiving azathioprine. Adverse events were reported in 55 patients (47.8%). No patients in either group required discontinuation of therapy due to adverse events.

Conclusion

Tofacitinib is more effective than azathioprine as maintenance therapy for steroid‐responsive ASUC at 1 year.

Subjects

MeSH terms (MEDLINE)

PiperidinesColitis, UlcerativePyrimidinesAzathioprineAdrenal Cortex HormonesImmunosuppressive AgentsHumansFemaleAdultMaleRetrospective StudiesMiddle AgedTreatment OutcomeMaintenance ChemotherapyAcute DiseasePropensity ScoreSeverity of Illness Index

Author keywords

acute severe ulcerative colitisazathioprineprednisolonetofacitinibulcerative colitis

Substances

tofacitinibPiperidinesPyrimidinesAzathioprineAdrenal Cortex HormonesImmunosuppressive Agents

Authors and institutions

  • Department of Gastroenterology, Dayanand Medical College and Hospital, Ludhiana, India.
  • Research Associate, Digestive Diseases Care Foundation, Ludhiana, India.
  • Research and Development Centre, Dayanand Medical College and Hospital, Ludhiana, India.
  • Division of Gastroenterology, Hepatology and Nutrition, Allegheny Health Network, Pittsburgh, Pennsylvania, USA.
  • Department of Internal Medicine, Dayanand Medical College and Hospital, Ludhiana, India.

ORCID profiles: Arshdeep Singh

Cite

APA

Singh, A., Bhardwaj, A., Sharma, R., Singh, D., Jain, D., Bansal, N., Kochhar, G. S., Midha, V., & Sood, A. (2025). Azathioprine or Tofacitinib as Maintenance Therapy in Corticosteroid‐Responsive Acute Severe Ulcerative Colitis. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.70246

Vancouver

Singh A, Bhardwaj A, Sharma R, Singh D, Jain D, Bansal N, et al. Azathioprine or Tofacitinib as Maintenance Therapy in Corticosteroid‐Responsive Acute Severe Ulcerative Colitis. Alimentary Pharmacology & Therapeutics. 2025. doi:10.1111/apt.70246

BibTeX
@article{Singh2025,
  author = {Singh, Arshdeep and Bhardwaj, Arshia and Sharma, Riya and Singh, Dharmatma and Jain, Devanshi and Bansal, Namita and Kochhar, Gursimran Singh and Midha, Vandana and Sood, Ajit},
  title = {Azathioprine or Tofacitinib as Maintenance Therapy in Corticosteroid‐Responsive Acute Severe Ulcerative Colitis},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2025},
  doi = {10.1111/apt.70246}
}
Start for free →